Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
14.69
+0.13 (0.89%)
Mar 6, 2026, 9:31 AM EST - Market open
Vor Biopharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 32.67 | 27.88 | 31.72 | 28.87 | 21.49 | 11.75 | |
| Research & Development | 304.62 | 93.31 | 94.32 | 64.55 | 47.53 | 31.62 | |
| Operating Expenses | 337.29 | 121.19 | 126.04 | 93.42 | 69.02 | 43.37 | |
| Operating Income | -337.29 | -121.19 | -126.04 | -93.42 | -69.02 | -43.37 | |
| Interest & Investment Income | 3.67 | 4.27 | 8.17 | 1.32 | 0.12 | 0.03 | |
| Other Non Operating Income (Expenses) | -2,086 | - | - | - | - | - | |
| Pretax Income | -2,450 | -116.91 | -117.86 | -92.09 | -68.9 | -43.34 | |
| Net Income | -2,450 | -116.91 | -117.86 | -92.09 | -68.9 | -43.34 | |
| Preferred Dividends & Other Adjustments | - | - | - | - | 1.23 | 5.93 | |
| Net Income to Common | -2,450 | -116.91 | -117.86 | -92.09 | -70.13 | -49.26 | |
| Shares Outstanding (Basic) | 6 | 3 | 3 | 2 | 2 | 0 | |
| Shares Outstanding (Diluted) | 6 | 3 | 3 | 2 | 2 | 0 | |
| Shares Change (YoY) | 66.44% | 2.25% | 69.88% | 18.30% | 15547.86% | - | |
| EPS (Basic) | -431.80 | -34.03 | -35.08 | -46.57 | -41.95 | -4611.25 | |
| EPS (Diluted) | -431.80 | -34.03 | -35.08 | -46.57 | -41.95 | -4611.25 | |
| Free Cash Flow | -144.67 | -99.89 | -101.36 | -93.61 | -73.04 | -40.45 | |
| Free Cash Flow Per Share | -25.50 | -29.08 | -30.17 | -47.33 | -43.69 | -3786.67 | |
| EBITDA | -333.56 | -117.66 | -122.54 | -90.89 | -67.58 | -42.76 | |
| D&A For EBITDA | 3.73 | 3.53 | 3.49 | 2.53 | 1.43 | 0.61 | |
| EBIT | -337.29 | -121.19 | -126.04 | -93.42 | -69.02 | -43.37 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.